Tr1X

Associate Director, Clinical Quality

San Diego, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in a scientific discipline or an equivalent combination of education, training, and/or experience, with a minimum of 8 years of related experience and at least 5 years in clinical quality management within the pharmaceutical or biotech industry. They must have experience and knowledge in establishing and managing quality systems, conducting vendor and investigator site audits, and overseeing CROs, along with working knowledge of FDA, ISO, and ICH regulatory guidance, clinical quality operations, and CTD/eCTD standards. Exceptional interpersonal skills are required.

Responsibilities

The Associate Director, Clinical Quality will oversee all aspects of Clinical Quality for internal and external processes, including CROs, vendors, and investigator sites; review internal and external documentation to ensure quality and regulatory compliance; document internal regulatory processes and evaluate quality events, incidents, queries, and complaints; utilize guidance regulatory documents and interpret them for clinical trials; conduct audits of clinical documentation, investigator sites, and vendors; lead root cause analyses and implement corrective and preventive action plans; collaborate with internal and external stakeholders to align quality strategies; assume a lead role in representing clinical quality at meetings and drafting policies and submissions; communicate compliance risks to senior management; assist in the development of documentation and systems; and support the Quality team’s needs while keeping abreast of new regulations and guidelines.

Skills

GCP
Clinical Quality
Regulatory Compliance
CRO Management
Vendor Management
Quality Assurance
Biotechnology
Autoimmune Diseases
Inflammatory Diseases
Cell Therapy
FDA Regulations

Tr1X

Develops cellular immunotherapies for autoimmune diseases

About Tr1X

Tr1X focuses on developing cellular immunotherapies aimed at treating autoimmune and inflammatory diseases. The company uses a proprietary platform to create cell therapy products that help to rebalance the immune system and restore its natural balance, which is essential for long-term health. Unlike many other companies in the biopharmaceutical sector, Tr1X specializes in first-in-class therapies that target the underlying causes of immune system disorders rather than just alleviating symptoms. The goal of Tr1X is to provide advanced therapeutic solutions that lead to lasting tolerance in patients, improving their quality of life.

San Diego, CaliforniaHeadquarters
2018Year Founded
$73MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
401(k) Company Match
Flexible Work Hours
Stock Options
Performance Bonus

Risks

Emerging competition in allogeneic Treg therapy could impact Tr1X's market share.
High manufacturing costs may pose financial risks for Tr1X.
Regulatory hurdles could delay Tr1X's product development and market entry.

Differentiation

Tr1X uses a proprietary platform for novel cellular immunotherapies.
The company focuses on allogeneic regulatory T-cell therapies for autoimmune diseases.
Tr1X's TRX103 is the first allogeneic engineered Tr1 regulatory T cell product.

Upsides

FDA clearance for TRX103 IND boosts Tr1X's credibility and market potential.
$75M Series A funding supports rapid development of Tr1X's therapies.
Growing autoimmune therapeutics market offers significant opportunities for Tr1X's products.

Land your dream remote job 3x faster with AI